ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2023

Treatment Burden on Once-Weekly Omarigliptin Versus Daily Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes: Randomized Controlled Trial (ONWARD-DPP4 Study).

Hitoshi Ishii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.